Vor Biopharma Inc.
VOR
$2.17
-$0.03-1.36%
NASDAQ
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Net Income | -1.66B | -118.60M | -116.91M | -112.46M | -118.09M |
| Total Depreciation and Amortization | 4.58M | 3.41M | 3.53M | 3.56M | 3.60M |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 1.54B | 13.44M | 13.72M | 12.88M | 12.48M |
| Change in Net Operating Assets | 4.71M | 1.49M | 5.00K | -3.59M | -2.22M |
| Cash from Operations | -113.60M | -100.26M | -99.66M | -99.62M | -104.24M |
| Capital Expenditure | -489.00K | -346.00K | -229.00K | -268.00K | -699.00K |
| Sale of Property, Plant, and Equipment | 799.00K | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 0.00 | 53.00M | 97.09M | 107.53M | 148.53M |
| Cash from Investing | 310.00K | 52.65M | 96.86M | 107.26M | 147.83M |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 55.85M | 55.77M | 56.05M | 456.00K | 741.00K |
| Repurchase of Common Stock | -187.00K | -206.00K | -333.00K | -325.00K | -475.00K |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 172.12M | -2.88M | -2.33M | 0.00 | 0.00 |
| Cash from Financing | 227.79M | 52.69M | 53.39M | 131.00K | 266.00K |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 114.50M | 5.08M | 50.59M | 7.77M | 43.86M |